GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocure Technology Inc (XCNQ:CURE) » Definitions » PB Ratio

Biocure Technology (XCNQ:CURE) PB Ratio : 0.88 (As of Jun. 05, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biocure Technology PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), Biocure Technology's share price is C$0.015. Biocure Technology's Book Value per Share for the quarter that ended in Mar. 2024 was C$0.02. Hence, Biocure Technology's PB Ratio of today is 0.88.

The historical rank and industry rank for Biocure Technology's PB Ratio or its related term are showing as below:

XCNQ:CURE' s PB Ratio Range Over the Past 10 Years
Min: 0.45   Med: 13.04   Max: 49.09
Current: 0.88

During the past 13 years, Biocure Technology's highest PB Ratio was 49.09. The lowest was 0.45. And the median was 13.04.

XCNQ:CURE's PB Ratio is not ranked
in the Biotechnology industry.
Industry Median: 2.535 vs XCNQ:CURE: 0.88

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Biocure Technology was 32.60% per year. The lowest was -81.70% per year. And the median was -4.40% per year.

Back to Basics: PB Ratio


Biocure Technology PB Ratio Historical Data

The historical data trend for Biocure Technology's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocure Technology PB Ratio Chart

Biocure Technology Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.88

Biocure Technology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.06 0.47 0.88 0.88

Competitive Comparison of Biocure Technology's PB Ratio

For the Biotechnology subindustry, Biocure Technology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocure Technology's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biocure Technology's PB Ratio distribution charts can be found below:

* The bar in red indicates where Biocure Technology's PB Ratio falls into.



Biocure Technology PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Biocure Technology's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=0.015/0.017
=0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Biocure Technology  (XCNQ:CURE) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Biocure Technology PB Ratio Related Terms

Thank you for viewing the detailed overview of Biocure Technology's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocure Technology (XCNQ:CURE) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9
Biocure Technology Inc is a South Korean-based Bio-Pharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It is in the process of preclinical trials of five majorly biosimilar products in South Korea, including Interferon Beta 1b, PEGFilgrastim, and Ranibizumab as well as CAR-T Cell Therapy. Interferon Beta 1b is used for treating relapsing forms of multiple sclerosis Filgrastim is used to treat neutropenia, a lack of certain white blood cells caused by bone marrow transplants, chemotherapy, and other conditions. Ranibizumab is used for treating macular degeneration. It is also used to treat a type of eye problem known as macular edema, as well as certain eye problems caused by diabetes.

Biocure Technology (XCNQ:CURE) Headlines